Significant Ownership of Schonfeld Strategic Advisors LLC

Signature - Title
/s/ Hung Luc - Hung Luc, Chief Compliance Officer
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Schonfeld Strategic Advisors LLC.

Notify me when Schonfeld Strategic Advisors LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Schonfeld Strategic Advisors LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CDNL Cardinal Infrastructure Group Inc. Class A Common Stock, par value $0.0001 per share 8.6% $32,238,584 1,285,430 Schonfeld Strategic Advisors LLC 31 Dec 2025
TERN Terns Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 4.9% $12,571,196 -$2,713,568 4,305,204 -18% Schonfeld Strategic Advisors LLC 31 Mar 2025
SKYE Skye Bioscience, Inc. Common Stock, par value $0.001 per share 3.6% $4,441,437 -$1,996,997 1,115,939 -31% Schonfeld Strategic Advisors LLC 30 Jun 2025
APLT Applied Therapeutics, Inc. Common Stock, par value $0.0001 per share 3.3% $1,823,678 -$1,596,482 4,676,097 -47% Schonfeld Strategic Advisors LLC 31 Mar 2025
RVPH Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share 2.8% $1,157,125 1,314,915 Schonfeld Strategic Advisors LLC 31 Dec 2024
FATE Fate Therapeutics, Inc. Common Stock, par value $0.001 per share 0.82% $1,050,024 -$7,679,831 937,521 -88% Schonfeld Strategic Advisors LLC 30 Jun 2025
MRSN Mersana Therapeutics, Inc. Common Stock, par value $0.0001 per share 0% $0 -$7,921,343 0 -100% Schonfeld Strategic Advisors LLC 31 Dec 2025
JZXN Jiuzi Holdings, Inc. Ordinary Shares, par value US$0.078 per share 0% $0 0 Schonfeld Strategic Advisors LLC 10 Feb 2026

Schedules 13D/G Reported by Schonfeld Strategic Advisors LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.